C/EBPγ is dispensable for steady-state and emergency granulopoiesis

• Miroslava Kardosova,
• Polina Zjablovskaja,
• Petr Danek,
• Pavla Angelisova,
• Lorena Lobo de Figueiredo-Pontes,
• Robert S. Welner,
• Tomas Brdicka,
• Sanghoon Lee,
• Daniel G. Tenen,
• Meritxell Alberich-Jorda

Affiliations

Miroslava Kardosova

Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic;Department of Cell Biology, Charles University, Faculty of Science, Prague, Czech Republic

Polina Zjablovskaja

Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic;CLIP-Childhood Leukaemia Investigation, Prague, Czech Republic;Department of Paediatric Haematology and Oncology, Charles University, Second Faculty of Medicine, Prague, Czech Republic

Petr Danek

Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

Pavla Angelisova

Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

Lorena Lobo de Figueiredo-Pontes

Hematology/Oncology Division of the Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Brazil

Robert S. Welner

Hematology/Oncology Department, University of Alabama at Birmingham, AL, USA

Tomas Brdicka

Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

Sanghoon Lee

Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Daniel G. Tenen

Cancer Science Institute, National University of Singapore, Singapore;Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA

Meritxell Alberich-Jorda

Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic;CLIP-Childhood Leukaemia Investigation, Prague, Czech Republic;Department of Paediatric Haematology and Oncology, Charles University, Second Faculty of Medicine, Prague, Czech Republic